Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
Categories Covered:PrEP (HIV Pre-Exposure Prophylaxis), HIV Prevention Methods, HIV Epidemiology, Adverse Events, Comorbidities, and HIV, HIV Testing, HIV Care and Services Outside the US, Providing Quality HIV Care, Managing Long-Term HIV Survivors, Managing People Newly Diagnosed With HIV, HIV Care Continuum, Physical Health Issues, Conceiving and Having a Baby, Women, Truvada (Tenofovir/FTC), PrEP (HIV Pre-Exposure Prophylaxis), HIV Prevention and Transmission, HIV Drugs In Development, Meeting the Costs of HIV Care, HIV Policy and Advocacy, HIV, Discrimination, and Law, HIV Education and Risk Management, HIV Treatment Strategies, TheBody en Español, Latinx People, Non-HIV Sexually Transmitted Infections, HIV Stigma and Discrimination, HIV Treatment and Medical Care, HIV Treatments in Development, FDA-Approved HIV Medications, Financial Issues, Living Well With HIV, Primary Care of People With HIV, HIV and Mental Health Care, Pregnancy, Childbirth, and HIV, Trans People, Efavirenz (Sustiva, Stocrin), Atazanavir (Reyataz), Flu (Influenza), Colds, and HIV, People Over 50, HIV Prevention for People With HIV, First-Line HIV Treatment, Managing HIV Drug Resistance
Latest by Sony Salzman
Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital
When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.
PrEP Use Is Correlated With an Increase in STIs, JAMA Study Finds
However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.
The Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How the CDC is Responding
Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.
Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People
Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.
Results of CDC-Funded Local Projects for MSM and Transgender People Unveiled at Prevention Conference
Project PrIDE demonstration studies in New York and Houston show that properly funded and well-designed outreach programs can impact a city's ability to provide better HIV services for underserved populations.
Native Americans Have HIV Treatment Adherence Rates on Par With Other Groups
Despite rising HIV rates and structural barriers to accessing care, American Indians and Alaska Natives do not have worse clinical outcomes when they're in care.
Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs
Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.
The Next Frontier of U=U Science
Undetectable equals untransmittable (U=U) has improved HIV prevention and tackled stigma, but there are still a few questions to answer.
Chemsex Doesn't Impact PrEP Adherence, New Study Finds
Although people living with HIV who "party and play" appear more likely to struggle with treatment adherence, new research suggests that concern does not apply to PrEP.
Advances in HIV Science Must Not Leave Needs of People Behind, Experts Urge
As the 2019 National HIV Prevention Conference kicked off on March 18, plenary speakers discussed not only recent biomedical advances, but also what is truly needed in heavily affected U.S. communities to end the epidemic.